In support of our findings, recent evidence shows CENPF siRNA knockdown resulting in cisplatin resistance in a variant small cell lung carcinoma and a non-small cell lung adenocarcinoma [29]. Here, CENPF is linked to non-small cell lung adenocarcinoma.